Phase II trial of methyl-GAG in advanced renal cancer.
作者信息
Zeffren J, Yagoda A, Watson R C, Natale R B, Blumenreich M S, Chapman R, Howard J
出版信息
Cancer Treat Rep. 1981 May-Jun;65(5-6):525-7.
PMID:6263478
Abstract
摘要
相似文献
1
Phase II trial of methyl-GAG in advanced renal cancer.
Cancer Treat Rep. 1981 May-Jun;65(5-6):525-7.
2
Phase II trial of combination methyl-GAG and vinblastine in the treatment of metastatic renal adenocarcinoma.
Cancer Treat Rep. 1982 Jul;66(7):1585-6.
3
Phase I--II trial of methyl-GAG in the treatment of patients with metastatic renal adenocarcinoma.
Cancer Treat Rep. 1981 Jan-Feb;65(1-2):17-20.
4
Methyl-GAG in advanced renal cell carcinoma.
Prog Clin Biol Res. 1982;100:663-7.
5
Mitoguazone in advanced renal carcinoma: a phase II trial of the Southwest Oncology Group.
Cancer Treat Rep. 1983 Dec;67(12):1139-40.
6
Phase II trial of mitoguazone in patients with advanced head and neck cancer.
Cancer Treat Rep. 1984 Oct;68(10):1301-2.
7
Methyl-GAG in advanced colon cancer: a phase II trial of the Southwest Oncology Group.
Cancer Treat Rep. 1982 Dec;66(12):2099-100.
8
The effects of Methyl-GAG on a transplantable murine renal cell adenocarcinoma.
Res Commun Chem Pathol Pharmacol. 1983 Jan;39(1):153-61.
9
Phase I-II trial of methyl-GAG in advanced colon cancer. a Southwest Oncology Group pilot study.
Cancer Clin Trials. 1981 Fall;4(3):277-9.
10
Phase II trial of methyl-G (methylglyoxal bis-guanylhydrazone) in patients with metastatic renal cell carcinoma.
Cancer Clin Trials. 1981 Winter;4(4):411-4.
引用本文的文献
1
Phase II evaluation of MGBG in non-small cell carcinoma of the lung. A Southwest Oncology Group study.
Invest New Drugs. 1983;1(1):89-93. doi: 10.1007/BF00180196.
Zotero 插件